Management of Gestational Weight Gain by Family Physicians: Seeking

Status Withdrawn

Clinical Trial Summary

Background The Institute of Medicine (IOM) published guidelines in 2009 for optimal gestational weight gain (GWG) during pregnancy. These guidelines include trajectories for optimal GWG, based on a woman's pre-pregnancy body mass index (BMI), to be used throughout the duration of a pregnancy. Although there is a significant association between the total GWG recommended by these guidelines and maternal and perinatal outcomes, research has demonstrated that only approximately one-third of pregnant women have total GWG within the recommended amounts. Factors known to influence GWG include maternal age, parity, being in a committed relationship and smoking. In addition, recommendations by primary care providers have been shown to influence actual GWG. Women appreciate advice from their primary care providers, however, despite this, there is evidence that many patients report not being advised at all about GWG by their primary care providers.

Relevance Excess weight gain in pregnancy has been shown to be a modifiable risk factor for excess weight in childhood, thus contributing to the intergenerational cycle of obesity. There is an opportunity to interfere with this cycle during the peri-pregnancy period, as women's motivation to engage in behaviour change is elevated and contact with their primary care providers is frequent.

Research Question and Hypothesis What impact does training family physicians to regularly refer to the IOM trajectories and provide feedback about GWG ("training in the use of IOM charts") during routine prenatal visits, compared to usual care, have on congruence of total GWG with IOM guidelines? Null Hypothesis: there is no difference in the congruence of total GWG with IOM guidelines between women whose family physicians were assigned to training in the use of the IOM charts and those whose family physicians were assigned to usual care.

Objectives

The following are the objectives for this study:

1. To compare the congruence of total GWG with IOM guidelines between women whose family physicians were assigned to training in the use of IOM trajectories and those whose family physicians were assigned to usual care.

2. To explore the relationship between other independent variables (maternal age, parity, committed relationship and smoking) and congruence of total GWG with IOM guidelines, for women whose family physicians were assigned to training in the use of IOM trajectories and for those whose family physicians were assigned to usual care.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01803698
Study type	Interventional
Source	Nova Scotia Health Authority
Contact
Status	Withdrawn
Phase	N/A
Start date	January 2017
Completion date	January 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04131023` - Metabolic Tracking and Weight Gain During Pregnancy	N/A
Completed	`NCT04294095` - My Baby My Move A Community Wellness Intervention	N/A
Completed	`NCT04330976` - Preventing Excessive Gestational Weight Gain Via Short Mobile Messages in WIC	N/A
Completed	`NCT00530439` - Lifestyle and Pregnancy: The Clinical Effect of Lifestyle Intervention During Pregnancy in Obese Women	N/A
Completed	`NCT04866823` - Meals for Moms: Medically-Tailored Meals for Women Who Had Gestational Diabetes	N/A
Recruiting	`NCT05576207` - BEP Supplementation Research in Bangladesh (JiVitA-BEP-IR)	N/A
Recruiting	`NCT05807594` - Healthy Mom Zone Gestational Weight Gain Management Intervention 2.0	N/A
Completed	`NCT03767699` - Medical Nutrition Therapy Program and Eating Behavior Questionnaires on Gestational Weight Gain
Recruiting	`NCT05119868` - Effects of the Mediterranean Diet During Pregnancy on the Onset of Allergies in the Offspring	N/A
Recruiting	`NCT03916354` - Maternal Gestational Weight Gain and Microbiota of Maternal and Infant
Completed	`NCT01331564` - eMOMS of Rochester	Phase 3
Completed	`NCT03957603` - Medical Nutrition Therapy Combined With TPF-DM in Pregnant Women With Gestational Diabetes Mellitus	N/A
Not yet recruiting	`NCT05855551` - Improving Birth Outcomes in Bangladesh	N/A
Completed	`NCT03936283` - Study of a Randomized Intervention Designed to Increase Exercise in Pregnancy	N/A
Not yet recruiting	`NCT05843903` - Teen Mom 2: Improving Black Adolescent Maternal Cardiometabolic Health	N/A
Not yet recruiting	`NCT06216925` - Teen Mom Study: A Confirmatory Pragmatic Cluster RCT	N/A
Recruiting	`NCT04421053` - Weight Gain Recommendations for Chinese Women With Gestational Diabetes Mellitus
Withdrawn	`NCT04025892` - Pregnancy Tracking Pilot	N/A
Recruiting	`NCT04731688` - A Weight Maintenance Program Promoting Fat Loss in Pregnancy in Women With Obesity	N/A
Active, not recruiting	`NCT04868110` - Preventing Excessive Weight Gain and Maternal and Infant Fat Accretion	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Management of Gestational Weight Gain by Family Physicians: Seeking Congruence With Guidelines

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms